Neurologian klinikka

Julkaisut 2001
Publications 2001

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Airas L et al. Encephalitis associated with Chlamydia pneumoniae.
2 Anichtchik OV et al. Distribution and modulation of histamine H3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
3 Bath PMW et al. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial.
4 Broberg E et al. Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis.
5 Brück A et al. Positron emission tomography shows that impaired frontal lobe functioning in Parkinson´s disease is related to dopaminergic hypofunction in the caudate nucleus.
6 Haapaniemi J et al. Botulinum toxin in the treatment of cricopharyngeal dysphagia.
7 Jääskeläinen S et al. Role of the dopaminergic system in chronic pain - a fluorodopa-PET study.
8 Kaasinen V et al. Personality traits and brain dopaminergic function in Parkinson´s disease .
9 Kaasinen V et al. Increased frontal (18F)flurodopa uptake in early Parkinson´s disease: sex differences in the prefrontal cortex.
10 Kaasinen V. et al. Sex differences in extrastriatal dopamine d(2)-like receptors in the human brain.
11 Kemppainen N et al. Different pattern of reduction of striatal dopamine reuptake sites in Alzheimer's disease and ageing.
12 Lamusuo S et al. [18F]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage.
13 Lamusuo S. Imaging the Epileptogenic Region with Positron Emission Tomography in Patients with Temporal Lobe Epilepsy.
14 Lee M. et al. Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson´s disease.
15 Lilja AM et al. Short-term effects of radiotherapy on attention and memory performances in patients with brain tumors.
16 Mattila PM et al. Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment.
17 Nurmi E. Progression of Nigrostrial Hypofunction in Parkinson´s Disease.
18 Nurmi E et al. The rate of progression in Parkinson´s disease: a 6-(18F) fluoro-L-dopa PET study.
19 Rinne JO et al. (18F)FDOPA and (18F)CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson´s disease.
20 Ruottinen HM et al. Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's diasease requires prolong imaging.
21 Tuominen S et al. Phenotype of a homozygous CADASIL patient in comparison to 9 age-matched heterozygous patients with the same R133C Notch3 mutation.
22 Åberg L. et al. A favorable response to antiparkinsonian treatment in juvenile neuronal ceroid lipofuscinosis.

Julkaisutietokanta 7.10.2004 Publications Data Base 7.10.2004